IDS 2013*
Chairs: Johnny Ludvigsson & John Wentworth
Immune-directed therapies for T1D: The ITN experience (#5)
8:45 AM
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: metabolic and mechanistic outcomes from the START trial (#6)
9:15 AM
Immune monitoring and stratification in Type 1 Diabetes therapeutic trials (#7)
9:45 AM